Bioniche Pharma launches generic antiarrhythmic agent

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Bioniche Pharma, a developer of injectable pharmaceuticals, has launched ibutilide fumarate injection, the generic equivalent of Pfizer's antiarrhythmic drug Corvert .

Bioniche of Lake Forest, Ill., said it will supply ibutilide fumarate injection in 0.1 mg/mL, 10 mL vials.

The product has a boxed warning relating to proarrhythmic effects including potentially fatal arrhythmias (e.g., polymorphic ventricular tachycardia) and consideration for use in patients with chronic atrial fibrillation.